Royal Bank of Canada
CRVO icon

Royal Bank of Canada’s CervoMed CRVO Stock Holding History

Royal Bank of Canada’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
+283
New +$1.48K ﹤0.01% 6843
2025
Q4 		– Sell
-1,572
Closed -$13K – 7233
2025
Q3 		$13K Sell
1,572
-716
-31% -$6.14K ﹤0.01% 6379
2025
Q2 		$14K Buy
2,288
+2,111
+1,193% +$18K ﹤0.01% 6373
2025
Q1 		$2K Sell
177
-36
-17% -$137 ﹤0.01% 6557
2024
Q4 		$0 Sell
213
-553
-72% -$5.38K ﹤0.01% 6937
2024
Q3 		$11K Buy
766
+255
+50% +$3.95K ﹤0.01% 6300
2024
Q2 		$9K Buy
+511
New +$11.2K ﹤0.01% 6368
2020
Q2 		– Hold
0
– – – 6663
2020
Q1 		– Hold
0
– – – 6715
2019
Q4 		– Hold
0
– – – 6856
2019
Q3 		– Hold
0
– – – 6750
2019
Q2 		– Hold
0
– – – 6913
2019
Q1 		– Hold
0
– – – 6843
2018
Q4 		– Hold
0
– – – 6803
2018
Q3 		– Hold
0
– – – 6751
2018
Q2 		– Hold
0
– – – 6556
2018
Q1 		– Hold
0
– – – 6402
2017
Q4 		– Hold
0
– – – 6583
2017
Q3 		– Hold
0
– – – 6742

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's CRVO Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in CervoMed (CRVO) in Q1 2026: 283 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #6843 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in CRVO as recently as Q3 2025.

Royal Bank of Canada first reported a position in CRVO in Q2 2024 and has held it in 7 quarters since. The position peaked at $14K in Q2 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Royal Bank of Canada held 283 shares of CervoMed worth $1K as of Q1 2026.
  • CervoMed was a new Royal Bank of Canada position in Q1 2026.
  • CervoMed made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6843 holding.
  • Royal Bank of Canada first reported a position in CervoMed in Q2 2024 and has held it in 7 quarters since.
  • Royal Bank of Canada's CervoMed position peaked at $14K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.